Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
It Can be Lonely in the Life of an MSL
Summary
In this episode, Tom Caravela welcomes special guest Trish Gorecki to share her insights and experiences as a Medical Science Liaison (MSL). The conversation delves into overcoming challenges and frustrations in the MSL role, emphasizing the importance of mentorship and networking. Trish discusses coping strategies for isolation, handling setbacks, and improving Key Opinion Leader (KOL) engagement. The episode provides a comprehensive look at burnout, work-life balance, and effective time management, especially during travel. Trish highlights essential resources and tools for MSLs, stressing the significance of continuous personal and professional development. The episode concludes with final advice for both current and aspiring MSLs.
Key Points
- Building and maintaining strong internal and external networks is crucial for overcoming the challenges and isolation often experienced by MSLs in the field.
- Persistence and strategic relationship-building are key to gaining access to KOLs, especially in a competitive and evolving market landscape.
- Taking personal responsibility for professional development through available resources, mentorship, and continuous learning can significantly enhance the effectiveness and satisfaction of MSLs.
Medical Science Liaison, MSL mentorship, KOL engagement, professional development, work-life balance
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary